Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol vs terazosin plus enalapril for hypertension and benign prostatic hyperplasia
IRCT20181128041777N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of carvedilol, terazosin and enalapril in hypertension (HTN) and benign prostatic hyperplasia (BPH) (2 arms), sponsored by Tabriz University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
carvedilolterazosinenalapril
03
Conditions
hypertension (HTN)benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20181128041777N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181128041777N1.